What Is a Primase? Its Role in DNA Replication

A primase is an enzyme that builds short RNA primers on a DNA template, giving DNA polymerases the starting point they need to copy DNA. DNA polymerases are powerful copying machines, but they share a fundamental limitation: none of them can start a new strand from scratch. They can only add nucleotides onto an existing strand. Primase exists to solve that problem, and it does so every time a cell divides, at every replication fork, thousands of times per genome.

Why DNA Replication Cannot Start Without a Primer

DNA polymerases extend a strand by adding one nucleotide at a time to the free 3′ end of an existing chain. Without that pre-existing end, the enzyme has nothing to grab onto. Primase fills this gap by synthesizing a short stretch of RNA, typically around 10 nucleotides long, that is complementary to the DNA template. Once that RNA primer is in place, DNA polymerase latches on and begins copying DNA in earnest. In other words, primase owes its existence entirely to the inability of DNA polymerases to start synthesis with just two loose nucleotides.¹

This requirement is not a quirk of one organism. Every domain of life, from bacteria to humans, depends on primase activity to begin DNA replication. Archaea and viruses use primases too. The enzymes differ in structure and complexity across these groups, but the core job remains identical: lay down a short RNA track so the replication machinery can get rolling.

Leading Strand, Lagging Strand, and Why Primase Works Overtime on One Side

When a cell copies its DNA, the double helix unwinds at a structure called the replication fork, exposing two single-stranded templates. One of these, the leading strand, points in the direction the fork is moving and can be copied continuously. Primase only needs to fire once on the leading strand, right at the origin, and then DNA polymerase cruises along without interruption.

The other template, the lagging strand, runs in the opposite direction. Because DNA polymerase can only build in one direction (5′ to 3′), it cannot simply follow the fork. Instead, the lagging strand is copied in short chunks called Okazaki fragments. Each fragment requires its own RNA primer laid down by primase, so the enzyme must repeatedly cycle back to the replication fork, recognize a new priming site, synthesize a fresh primer, and hand it off to the DNA polymerase. This means primase is working far harder on the lagging strand than on the leading strand.

The handoff between primase and the lagging-strand polymerase is not instantaneous. Studies using the bacteriophage T7 replication system showed that primer utilization by DNA polymerase is actually slower than primer formation itself. What limits the pace of lagging-strand synthesis is not how fast primase makes the primer, but how slowly the primer is released from primase and transferred to the polymerase.²

Primase as a Molecular Brake

Here is something that surprised researchers: primase does not just enable replication, it also slows it down. DNA polymerases synthesize DNA at a blistering pace compared to the rate at which primase makes RNA primers. If the leading-strand polymerase just kept running at full speed, it would race far ahead of the lagging strand, potentially creating dangerous stretches of exposed single-stranded DNA.

Experiments on the T7 replication system revealed that each time primase synthesizes a new primer on the lagging strand, the leading strand temporarily pauses. Primase acts as a molecular brake, transiently halting fork progression until the lagging strand catches up. This coordination prevents the two halves of the replication fork from drifting apart during the inherently slower enzymatic steps on the lagging strand.³ The replication fork, in other words, is not a runaway train. It has a built-in pacing mechanism, and primase is the one applying the brakes.

How Primase Recognizes Where to Start

Primase does not just land anywhere on a DNA template. In bacteria and bacteriophages, the enzyme recognizes specific short sequences in the single-stranded DNA. In bacteriophage T7, for instance, the primase homes in on the trinucleotide sequence 5′-GTC-3′. A zinc-binding motif within the enzyme is essential for this recognition: it physically contacts bases in the template to verify it has found the right spot.⁴ Interestingly, T7 primase does not bind its recognition sequence much more tightly than random DNA. What dramatically boosts binding is the presence of the specific nucleotides that will be incorporated into the primer, suggesting the enzyme verifies both template sequence and available building blocks before committing to synthesis.⁵

In bacterial primases like DnaG, the zinc-binding domain handles template recognition while a separate RNA polymerase domain carries out catalysis. The two domains work together: structural studies of the enzyme from Bacillus subtilis showed that the tethered zinc-binding domain plays an important role in how primase interacts with its preferred template sequences.⁶

How Primase Knows When to Stop

RNA primers are short for a reason. They are temporary scaffolds, not permanent parts of the genome, so the cell wants them as brief as possible while still being long enough to serve their purpose. But how does primase “know” it has made a primer of the right length?

Research on archaeal primase described the enzyme as functioning like a nanoscale caliper. Rather than counting nucleotides one by one, the enzyme uses its own physical dimensions to measure the growing primer. When the RNA reaches a certain length, the geometry of the enzyme no longer accommodates further extension, and synthesis stops.⁷

In eukaryotes, the picture involves a more complex machine. The primase works as part of a larger assembly called DNA polymerase α-primase (often written as Pol α-primase), and a “linker stretching” mechanism has been proposed. When the RNA primer has been extended by roughly one full turn of the DNA double helix (about 10 base pairs), flexible linkers connecting different parts of the complex become fully stretched. That physical tension triggers the release of the catalytic domain from the template, ending primer synthesis.⁸ The enzyme essentially uses its own architecture as a molecular ruler.

Bacterial Primase Versus Eukaryotic Primase

Despite performing the same basic job, primases in bacteria and in eukaryotes look quite different structurally. Bacterial primase, called DnaG, is a single protein with three functional domains: a zinc-binding domain for template recognition, an RNA polymerase domain for catalysis, and a C-terminal domain that interacts with the replicative helicase DnaB.⁹ That last interaction matters: direct physical contact between DnaG and DnaB is necessary for efficient primer synthesis, and mutations that weaken the contact significantly reduce priming activity.¹⁰ Furthermore, the C-terminal domain of primase that binds DnaB also stimulates the helicase’s unwinding and ATPase activities, so the two enzymes enhance each other’s performance.¹¹

Crystal structures of the DnaB hexamer bound to the helicase-binding domain of DnaG show that up to three primase molecules can dock onto the six-subunit helicase ring. Binding of the primase domains stabilizes the helicase in a particular conformation that may increase its processivity, meaning it can unwind longer stretches of DNA without falling off.¹²

Eukaryotic primase, by contrast, is a two-subunit enzyme (a small catalytic subunit and a larger regulatory subunit) that operates as part of the four-subunit Pol α-primase complex.¹³ The small subunit handles both primer initiation and elongation using the same set of active-site residues. The large subunit, while evolutionarily conserved across archaea and eukaryotes, does not appear to participate directly in catalysis. Instead, it helps organize the complex and regulate primer handoff.¹⁴

From RNA Primer to DNA Extension and Handoff

In eukaryotes, primase does not simply drop its primer and walk away. Once the RNA primer is roughly 7 to 10 nucleotides long, the primer-template is handed off internally to the DNA polymerase α (Pol α) component of the same complex. Pol α then extends the primer by about 20 nucleotides of DNA, creating a short chimeric RNA-DNA strand. This handoff is mediated by the regulatory subunit of primase and by the high degree of flexibility between the modules of the complex, which undergo dramatic configurational rearrangements during the process.¹⁵ Recent structural work captured the complex synthesizing across two separate active sites while maintaining contact with both ends of the primer-template duplex, revealing just how acrobatic this molecular machine really is.¹⁶

One trade-off of this arrangement: the Pol α-primase complex lacks proofreading ability, making it roughly 10- to 100-fold less accurate than the other major replicative polymerases. The cell compensates by having DNA polymerase δ, which takes over downstream, proofread and correct errors introduced by Pol α-primase.¹⁷

What Happens to RNA Primers After They Have Done Their Job

RNA does not belong in the finished DNA product. After DNA polymerase extends each Okazaki fragment, the leftover RNA primers must be removed and replaced with DNA before the fragments can be joined into a continuous strand. In eukaryotic cells, this cleanup happens through at least two pathways working in parallel.

In one pathway, the advancing DNA polymerase displaces the RNA primer of the preceding Okazaki fragment, creating a flap of single-stranded nucleic acid. Nucleases called Fen1 and Dna2 then clip these flaps. In a second pathway, the enzymes RNase H2 and Exo1 digest the RNA-DNA primer directly without flap formation. Direct visualization experiments in living cells confirmed that both mechanisms operate and are important for completing lagging-strand synthesis.¹⁸ Once the RNA is gone and replaced with DNA, a ligase enzyme seals the nicks, producing an unbroken daughter strand.

PrimPol and Rescue Priming at Damaged DNA

Cells face a constant barrage of DNA damage from UV light, reactive chemicals, and metabolic byproducts. When the replication fork runs into a lesion it cannot copy past, it stalls. Left unresolved, stalled forks can collapse and generate dangerous breaks. Eukaryotic cells have a backup plan in the form of an enzyme called PrimPol.

PrimPol is a dual-function enzyme: it can act both as a translesion synthesis polymerase (copying past damaged bases) and as a primase (laying down a new primer downstream of the lesion so replication can restart). Experiments separating these two activities showed that the primase function, not the polymerase function, is the critical one for tolerating DNA damage. Cells lacking PrimPol are hypersensitive to UV and to drugs that stall replication, and complementing them with a version of PrimPol that retains only its primase activity restores damage tolerance.¹⁹ PrimPol is recruited to stalled forks through its interaction with RPA, the protein that coats exposed single-stranded DNA at sites of replication stress.²⁰

The discovery of PrimPol expanded the view of what primases do in the cell. The conventional primase in the Pol α-primase complex is a dedicated replication enzyme. PrimPol, by contrast, is a stress-response tool, coming off the bench when replication hits trouble.²¹

Primase Beyond Standard Replication

The Pol α-primase complex shows up in several cellular processes that go beyond copying the genome during S phase. One of the most surprising is telomere maintenance. Telomeres, the protective caps at chromosome ends, are extended by telomerase, which adds repetitive DNA sequences to the 3′ overhang. But this creates a problem: the complementary 5′ strand, called the C-strand, is left too short. A complex called CST (Ctc1-Stn1-Ten1) recruits Pol α-primase to fill in this gap. CST-Pol α-primase replenishes the lost sequences through a fill-in reaction, and the CST complex also regulates telomere length by preventing telomerase from over-extending the chromosome ends.²²

Pol α-primase also participates in DNA double-strand break repair. When a break occurs, the ends are often chewed back by nucleases to generate 3′ overhangs, a step needed for homologous recombination. But if those overhangs get too long, repair goes awry. Recent work showed that CST-Pol α-primase can fill in resected breaks, controlling overhang length. This fill-in activity is particularly relevant in cells that lack the BRCA1 tumor suppressor and are treated with PARP inhibitors, a common strategy in cancer therapy.²³ The Pol α-primase complex also plays roles in chromatin assembly and in signaling the presence of DNA damage, reinforcing the view that it is a more versatile machine than the textbook description of “makes primers” suggests.²⁴

Viral Primases

Viruses that replicate their own DNA also need priming activity, and their primases can look quite different from those of their hosts. Herpes simplex virus-1 (HSV-1), for example, encodes a three-protein helicase-primase complex. The primase subunit, UL52, belongs to the archaeo-eukaryotic primase superfamily and contains a catalytic core that is structurally distinct from the bacterial DnaG fold. UL52 also has a zinc-finger domain: mutations in the conserved cysteine residues of this domain abolished primase activity and severely reduced DNA binding.²⁵

Because viral primases diverge structurally from the host enzyme, they present an attractive target for antiviral drugs. The HSV helicase-primase inhibitor pritelivir, for instance, exploits these structural differences to block viral DNA replication without interfering with the host’s own priming machinery. The principle is the same one that drives antibiotic research targeting bacterial DnaG: if you can find structural features unique to the pathogen’s primase, you can design drugs that shut it down selectively.

Primase as a Drug Target

The structural differences between bacterial and human primases make DnaG an appealing target for new antibiotics. Bacterial primase uses a fold called TOPRIM for catalysis, while eukaryotic primase uses an unrelated fold called AEP. Because the two enzymes are built so differently, a drug designed to jam DnaG should not interfere with the human version. Blocking primase activity is expected to halt bacterial DNA replication, and growing evidence suggests that halting replication kills bacteria outright rather than merely slowing their growth.²⁶

Several compounds that inhibit DnaG have already been identified through biochemical screening, including both DNA-intercalating agents and non-intercalators like suramin. Work on DnaG from Bacillus anthracis, the anthrax-causing bacterium, yielded several inhibitor leads.²⁷ Researchers have even explored whether primase inhibitors could be made narrow-spectrum, targeting only Gram-positive bacteria, for example, by exploiting differences in how the C-terminal helicase-binding domain folds between Gram-positive and Gram-negative species. In Gram-positive bacteria, this domain folds into a compact shape that creates a small-molecule binding site, a feature absent in Gram-negative counterparts.²⁸

On the cancer side, the two subunits of eukaryotic primase (PRIM1 and PRIM2) are emerging as potential therapeutic targets. Because rapidly dividing cancer cells depend heavily on replication machinery, disrupting primase function could selectively harm tumor cells while sparing slower-dividing normal tissue. Strategies targeting PRIM1 or PRIM2 are under investigation as potential cancer treatment approaches.¹⁷ This work is still in early stages, but it underscores how a basic replication enzyme discovered decades ago continues to open new doors in medicine.